TherapeuticsMD, Inc. (TXMD) Stock

TherapeuticsMD, Inc. is a prominent women's healthcare company based in Boca Raton, Florida, dedicated to advancing treatments and products that cater specifically to women's health needs across the United States. The company's portfolio includes a range of therapeutic options aimed at addressing various women's health concerns.

Among its notable offerings, TherapeuticsMD provides IMVEXXY, designed to alleviate moderate-to-severe dyspareunia, a common symptom of menopause. Another flagship product is BIJUVA, a bio-identical hormone therapy combining 17�-estradiol and progesterone to manage moderate-to-severe vasomotor symptoms associated with menopause. Additionally, the company offers ANNOVERA, an innovative ring-shaped contraceptive vaginal system providing a long-acting contraceptive option.

Beyond its current products, TherapeuticsMD is actively engaged in advancing preclinical projects. These initiatives include TX-005HR, a transdermal progesterone-alone cream, and TX-006HR, a transdermal cream combining estradiol and progesterone. Furthermore, the company is developing TX-007HR and TX-008HR as transdermal patch product candidates, along with TX-009HR, an oral formulation combining progesterone and estradiol. Complementing its pharmaceutical endeavors, TherapeuticsMD also manufactures and distributes branded and generic prescription prenatal vitamins under various well-recognized brands such as vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1.